Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAGALS: TDP-43 and Nrf-2 in ALS
NCT06230562Unknown
- Sponsor
- University Hospital Tours
- Start
- Feb 2024
- Primary completion
- Aug 2025
01
Overview
Open-label trial (2 arms), sponsored by University Hospital Tours. Primary endpoints: Presence of TDP-43 aggregates in PBMC at 6 months and PBMC accompanied by a protein expression profile under Nrf-2 control at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT06230562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06230562.